CD34 and immunodeficiency disease: Gene therapy for immunodeficiencies is commonly performed by inserting a normal copy (native or codon optimized) of the defective gene into the patient’s CD34+ enriched HSPCs isolated from bone marrow (BM) or mobilized peripheral blood (mPB).